2,997 articles

Corrigendum: SERPIND1 affects the malignant biological behavior of epithelial ovarian cancer via the PI3K/AKT pathway: a mechanistic study

in Molecular and Cellular Oncology

• Qian Guo
• Liancheng Zhu
• Caixia Wang
• Shuang Wang
• Xin Nie
• Juanjuan Liu
• Qing Liu
• Yingying Hao
• Xiao Li
• Bei Lin

Expression and clinical significance of Numb and Notch-1 proteins between tissue of colon cancer and regional lymph node metastases

in Molecular and Cellular Oncology

• Jingyou Ma
• Jinpeng Zhen
• Ningbao Yang
• Changjuan Meng
• Yanjun Lian

Corrigendum: Exogenous let-7a-5p induces A549 lung cancer cell death through BCL2L1-mediated PI3Kγ signaling pathway

in Molecular and Cellular Oncology

• Shuyin Duan
• Songcheng Yu
• Teng Yuan
• Sanqiao Yao
• Lin Zhang

A real-world study: third-line treatment options for metastatic colorectal cancer

in Molecular and Cellular Oncology

• Chen Wu
• Shuai Li
• Xinfang Hou

circUBE2G1 interacts with hnRNPU to promote VEGF-C-mediated lymph node metastasis of lung adenocarcinoma

in Molecular and Cellular Oncology

• Yuting Li
• Hui Chen
• Yue Zhao
• Qilu Yan
• Lulu Chen
• Qibin Song

Sialylation inhibition improves macrophage mediated tumor cell phagocytosis of breast cancer cells triggered by therapeutic antibodies of different isotypes

in Molecular and Cellular Oncology

• Marta Lustig
• Christoph Hahn
• Marie Leangen Herigstad
• Jan Terje Andersen
• Jeanette H. W. Leusen
• Renate Burger
• Thomas Valerius

Editorial: Unveiling the potential of CTCs in drug resistance mechanisms and personalized medicine

in Molecular and Cellular Oncology

• Chiara Nicolazzo
• Elisa Frullanti
• Paola Gazzaniga
• Maria Palmieri

When a negative (charge) is not a positive: sialylation and its role in cancer mechanics and progression

in Molecular and Cellular Oncology

• Issa Funsho Habeeb
• Toheeb Eniola Alao
• Daniella Delgado
• Alexander Buffone

Repurposing of PSMA-targeted diagnostic and therapeutic agents for the detection and treatment of giant cell tumors of bone

in Molecular and Cellular Oncology

• Brenna C. McAllister
• Nooshin Mesbahi
• Esther E. Dodson
• Sakinah Abdulsalam
• Clifford E. Berkman
• Leslie A. Caromile

Retraction: MiR-365a-3p-mediated regulation of HELLS/GLUT1 axis suppresses aerobic glycolysis and gastric cancer growth

in Molecular and Cellular Oncology

The skeleton: an overlooked regulator of systemic glucose metabolism in cancer?

in Molecular and Cellular Oncology

• Rucha Ronghe
• Adriana A. S. Tavares

The evolution of BRAF-targeted therapies in melanoma: overcoming hurdles and unleashing novel strategies

in Molecular and Cellular Oncology

• Saber Imani
• Ghazaal Roozitalab
• Mahdieh Emadi
• Atefeh Moradi
• Payam Behzadi
• Parham Jabbarzadeh Kaboli

Integrin α2 in the microenvironment and the tumor compartment of digestive (gastrointestinal) cancers: emerging regulators and therapeutic opportunities

in Molecular and Cellular Oncology

• Tiantian Liu
• Yanmei Gu
• Yuyu Zhang
• Yumin Li

Research progress of the SLFN family in malignant tumors

in Molecular and Cellular Oncology

• Jiale Yu
• Zhijuan Guo
• Junyi Zhang

The intricate interplay between ferroptosis and efferocytosis in cancer: unraveling novel insights and therapeutic opportunities

in Molecular and Cellular Oncology

• Ali Ahmadizad Firouzjaei
• Samira Mohammadi-Yeganeh

Development and validation of a tumor marker-based model for the prediction of lung cancer: an analysis of a multicenter retrospective study in Shanghai, China

in Molecular and Cellular Oncology

• Sheng Hu
• Qiang Guo
• Jiayue Ye
• Hongdan Ma
• Manyu Zhang
• Yunzhe Wang
• Bingen Wan
• Shengyu Qiu
• Xinliang Liu
• Guiping Luo